Sigma Healthcare Crecimiento futuro

Future controles de criterios 6/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Sigma Healthcare de 47.3% y 21.5% por año respectivamente. Se prevé que el BPA crezca en un 34.4% al año. Se espera que la rentabilidad financiera sea de 61.6% en 3 años.

Información clave

47.3%

Tasa de crecimiento de los beneficios

34.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	25.2%
Tasa de crecimiento de los ingresos	21.5%
Rentabilidad financiera futura	61.6%
Cobertura de analistas	Low
Última actualización	10 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Sigma Healthcare Limited's (ASX:SIG) Subdued P/S Might Signal An Opportunity

Feb 24

Is There An Opportunity With Sigma Healthcare Limited's (ASX:SIG) 49% Undervaluation?

Jan 05

Sigma Healthcare (ASX:SIG) Will Pay A Dividend Of AU$0.01

Mar 31

Some Investors May Be Worried About Sigma Healthcare's (ASX:SIG) Returns On Capital

Dec 08

The Returns On Capital At Sigma Healthcare (ASX:SIG) Don't Inspire Confidence

May 11

Shareholders Shouldn’t Be Too Comfortable With Sigma Healthcare's (ASX:SIG) Strong Earnings

Mar 29

Sigma Healthcare Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Mar 24

How Many Sigma Healthcare Limited (ASX:SIG) Shares Do Institutions Own?

Feb 16

We Think Sigma Healthcare (ASX:SIG) Has A Fair Chunk Of Debt

Jan 19

What Type Of Returns Would Sigma Healthcare's(ASX:SIG) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Dec 31

Are Insiders Buying Sigma Healthcare Limited (ASX:SIG) Stock?

Dec 13

Previsiones de crecimiento de beneficios e ingresos

ASX:SIG - Estimaciones futuras de los analistas y datos financieros pasados (AUD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2027	8,900	725	585	1,018	2
6/30/2026	8,263	606	467	515	2
6/30/2025	5,384	270	625	-145	2
7/31/2024	3,481	-3	-69	-64	N/A
4/30/2024	3,401	1	-16	-11	N/A
1/31/2024	3,322	5	37	42	N/A
10/31/2023	3,414	10	29	39	N/A
7/31/2023	3,506	15	21	36	N/A
4/30/2023	3,583	8	64	86	N/A
1/31/2023	3,660	2	107	136	N/A
10/31/2022	3,605	-3	71	98	N/A
7/31/2022	3,550	-7	36	61	N/A
4/30/2022	3,498	-7	-12	7	N/A
1/31/2022	3,446	-7	-60	-46	N/A
10/31/2021	3,469	20	-51	-33	N/A
7/31/2021	3,491	47	-42	-20	N/A
4/30/2021	3,446	45	-53	-16	N/A
1/31/2021	3,400	44	-65	-13	N/A
10/31/2020	3,205	12	-21	37	N/A
7/31/2020	3,009	-19	23	87	N/A
4/30/2020	3,127	-16	84	145	N/A
1/31/2020	3,244	-12	146	203	N/A
10/31/2019	3,570	7	87	153	N/A
7/31/2019	3,897	26	28	104	N/A
4/30/2019	3,937	31	-36	56	N/A
1/31/2019	3,977	37	-100	8	N/A
10/31/2018	4,015	39	-53	46	N/A
7/31/2018	4,054	41	-7	84	N/A
4/30/2018	4,074	48	N/A	77	N/A
1/31/2018	4,094	55	N/A	71	N/A
10/31/2017	4,156	56	N/A	94	N/A
7/31/2017	4,218	57	N/A	117	N/A
4/30/2017	4,292	55	N/A	131	N/A
1/31/2017	4,366	53	N/A	146	N/A
10/31/2016	4,149	54	N/A	108	N/A
7/31/2016	3,932	55	N/A	71	N/A
4/30/2016	3,697	53	N/A	51	N/A
1/31/2016	3,461	51	N/A	32	N/A
10/31/2015	3,388	50	N/A	35	N/A
7/31/2015	3,315	49	N/A	39	N/A
4/30/2015	3,229	51	N/A	50	N/A
1/31/2015	3,142	53	N/A	61	N/A
10/31/2014	3,077	56	N/A	78	N/A
7/31/2014	3,012	60	N/A	94	N/A
4/30/2014	2,993	57	N/A	87	N/A
1/31/2014	2,973	54	N/A	80	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que SIG sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.6%).

Beneficios vs. Mercado: Se prevé que SIG sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que SIG sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (21.5% al año) de SIG crezcan más rápidamente que los del mercado Australian (5.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos (21.5% al año) de SIG crezcan más rápidamente que un 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de SIG sea muy elevada dentro de 3 años (61.6%).

Sigma Healthcare Crecimiento futuro

Future controles de criterios 6/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 7.3% to AU$1.24

Consensus EPS estimates fall by 16%

Price target increased by 9.8% to AU$0.98

Consensus EPS estimates increase by 29%

Price target increased by 9.9% to AU$0.94

Consensus EPS estimates fall by 24%

Recent updates

First half 2025 earnings released: EPS: AU$0.002 (vs AU$0.011 in 1H 2024)

First half dividend of AU$0.005 announced

Price target increased by 7.3% to AU$1.24

Sigma Healthcare Limited to Report Q2, 2025 Results on Sep 25, 2024

New minor risk - Earnings quality

Consensus EPS estimates fall by 16%

First half dividend of AU$0.005 announced

Price target increased by 9.8% to AU$0.98

Sigma Healthcare Limited to Report Fiscal Year 2024 Results on Mar 21, 2024

Consensus EPS estimates increase by 29%

Price target increased by 9.9% to AU$0.94

Sigma Healthcare Limited's (ASX:SIG) Subdued P/S Might Signal An Opportunity

New major risk - Shareholder dilution

Is There An Opportunity With Sigma Healthcare Limited's (ASX:SIG) 49% Undervaluation?

New minor risk - Shareholder dilution

Sigma Healthcare Limited has filed a Follow-on Equity Offering.

Sigma Healthcare Limited has filed a Follow-on Equity Offering.

Sigma Healthcare Limited has filed a Follow-on Equity Offering.

Sigma Healthcare Limited, Annual General Meeting, May 30, 2024

Less than half of directors are independent

Sigma Healthcare Limited Announces Christopher Graham Roberts as Director

Consensus EPS estimates fall by 24%

Sigma Healthcare Limited Declares Fully Franked Dividend for the Six Month Ended July 31, 2023, Payable on October 11, 2023

Sigma Healthcare Limited to Report First Half, 2024 Results on Sep 20, 2023

Sigma Healthcare Limited Appoints Mark Conway as CFO, Effective from 1 November 2023

Sigma Healthcare Limited Announces Executive Changes

Price target increased by 21% to AU$0.69

Less than half of directors are independent

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Sigma Healthcare Limited Announces Board Changes

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.001 loss in 1H 2022)

Sigma Healthcare Limited Declares Interim Fully Franked Dividend, Payable on 12 October 2022

Sigma Healthcare Limited Announces Executive Changes

Sigma Healthcare Limited Appoints Nigel Simonsz as Chief Financial Officer, Effective 29 August 2022

Sigma Healthcare Limited Appoints Nigel Simonsz as Chief Financial Officer, Effective 29 August 2022

Independent Non-Executive Director recently bought AU$56k worth of stock

Sigma Healthcare Limited Announces Appointment of Josephine De Martino as Interim Chief Financial Officer

Sigma Healthcare Limited, Annual General Meeting, May 10, 2023

Sigma Healthcare (ASX:SIG) Will Pay A Dividend Of AU$0.01

Full year 2022 earnings: Revenues in line with analyst expectations

Sigma Healthcare Limited Provides Earnings Guidance for the Year 2023

Consensus estimates of losses per share improve by 36%

Consensus EPS estimates fall by 22%

Some Investors May Be Worried About Sigma Healthcare's (ASX:SIG) Returns On Capital

Price target decreased to AU$0.60

Consensus EPS estimates fall to -AU$0.011

Simon Mawhinney Opposes Sigma Healthcare’s Bid to Australian Pharmaceutical

First half 2022 earnings released: AU$0.001 loss per share (vs AU$0.004 loss in 1H 2021)

Independent Non-Executive Director has left the company

The Returns On Capital At Sigma Healthcare (ASX:SIG) Don't Inspire Confidence

Upcoming dividend of AU$0.01 per share

Shareholders Shouldn’t Be Too Comfortable With Sigma Healthcare's (ASX:SIG) Strong Earnings

Sigma Healthcare Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Full year 2021 earnings released: EPS AU$0.061 (vs AU$0.013 loss in FY 2020)

How Many Sigma Healthcare Limited (ASX:SIG) Shares Do Institutions Own?

New 90-day high: AU$0.73

New 90-day high: AU$0.63

We Think Sigma Healthcare (ASX:SIG) Has A Fair Chunk Of Debt

What Type Of Returns Would Sigma Healthcare's(ASX:SIG) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

New 90-day high: AU$0.61

Are Insiders Buying Sigma Healthcare Limited (ASX:SIG) Stock?

CEO, MD & Executive Director recently bought AU$135k worth of stock

New 90-day low: AU$0.56

Sigma Healthcare Appoints Jackie Pearson as Chief Financial Officer

CEO, MD & Executive Director recently bought AU$296k worth of stock

New 90-day low: AU$0.58

First half earnings released

Sigma Healthcare Limited Announces No Interim Dividend for the Half Year Ended 31 July 2020

Price target raised to AU$0.69